Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

BACKGROUND: Coadministration of mometasone furoate (MF) and formoterol fumarate (F) produces additive effects for improving symptoms and lung function and reduces exacerbations in patients with asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the relative systemic...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kosoglou, Teddy, Hubbell, James, Xuan, Fengjuan, Cutler, David L, Meehan, Alan G, Kantesaria, Bhavna, Wittmer, Bret A
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2013
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3595976/
https://ncbi.nlm.nih.gov/pubmed/23525511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S36592
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы